Showing 1101-1110 of 2820 results for "".
Anti-Alpha-Synuclein Therapies in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/anti-alpha-synuclein-therapies-in-parkinsons-disease/30196/Could therapies developed to stop cancers be the next breakthrough for neurodegenerative disorders?Levodopa: 50 and Fabulous
https://practicalneurology.com/diseases-diagnoses/movement-disorders/levodopa-50-and-fabulous/30365/- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31072/January 2008 Issue of Practical Neurology Highlights Esteemed Editorial and Contributor TeamThe January 2008 issue of *Practical Neurology* underscores its commitment to delivering high-quality neurological insights through a distinguished editorial and contributor team. Dr. Stephen Gollomp, Chief o
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31089/The November 2007 issue of Practical Neurology features a distinguished editorial leadership and a diverse panel of contributors dedicated to advancing neurological medicine. Chief Medical Editor Dr. Stephen Gollomp, Chief of Neurology at Lankenau Hospital and Clinical Professor at Thomas Jefferson
- Editorial Board/Contributorshttps://practicalneurology.com/columns/practice-management/editorial-boardcontributors/31351/Exploring Advanced Neurological Practices: Insights from Leading ExpertsIn the latest issue of *Practical Neurology*, healthcare professionals are presented with a comprehensive collection of articles curated by an esteemed editorial board and a cadre of distinguished contributors. This edition delv
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31110/Adrenal insufficiency remains a significant clinical concern, particularly in patients undergoing long-term glucocorticoid therapy for conditions such as multiple sclerosis (MS). A pertinent case involves a 54-year-old woman with a decade-long history of primary progressive MS, managed with monthly
- Defensive Medicine: Is It Putting Barriers Between You and Your Patients?https://practicalneurology.com/columns/practice-management/defensive-medicine-is-it-putting-barriers-between-you-and-your-patients/31341/Defensive Medicine in Neurology: Balancing Patient Care and Malpractice RisksRising malpractice liabilities are compelling neurologists to adopt defensive medicine practices, significantly impacting patient care and escalating healthcare costs. In a February 2006 issue of *Practical Neurology*, Asso
- Managing Sleep and Sleepiness in Parkinson's Diseasehttps://practicalneurology.com/diseases-diagnoses/sleep/pn0908-sleep-and-pd-pdf/30998/Sleep disturbances are highly prevalent in patients with Parkinson’s Disease (PD), affecting between 60% and 98% of individuals. These disturbances encompass a range of issues, including nocturnal sleep fragmentation, reduced slow-wave and REM sleep, decreased total sleep time, and impaired sleep ef
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31058/The January 2008 issue of *Practical Neurology* features a distinguished editorial board and contributor lineup, underscoring the journal’s commitment to advancing neurological medicine. Led by Dr. Stephen Gollomp, Chief of Neurology at Lankenau Hospital and Clinical Professor at Thomas Jefferson Un
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31187/Levodopa’s Enduring Role in Parkinson’s Disease Management: A Reflective AnalysisAs the medical community commemorates the 40th anniversary of the Cotzias study, which revolutionized Parkinson’s disease (PD) treatment with the introduction of levodopa, its sustained prominence remains a topic of sig